December 20, 2024 In 2024, CMS unveiled a new quality measure to assess how well hospitals have executed strategies for systems-based improvement for patient safety and quality of care. These… Read more »
December 6, 2024 On December 3, 2024, the United States District Court for the Eastern District of Texas (Sherman Division) entered a preliminary injunction suspending enforcement of the Corporate Transparency… Read more »
June 18, 2024 On June 13, 2024, after over a year and a half of litigation, the United States Supreme Court issued an opinion in the mifepristone case. The Supreme… Read more »
May 1, 2023 On March 31, a Connecticut trial court upheld privilege afforded to Patient Safety Work Product (“PSWP”) in what is believed to be the state’s first reported opinion… Read more »
April 28, 2023 The Centers for Medicare and Medicaid (CMS) have kept true to their commitment to focus on hospital price transparency in 2023 again yesterday announcing plans to strengthen… Read more »
April 28, 2023 On April 21, 2023, the United States Supreme Court settled almost a month-long dispute regarding the current status of mifepristone prescriptions. Specifically, the Court granted a stay… Read more »
April 19, 2023 On Friday, April 14, 2023, The United States Attorney’s Office for the Eastern District of Virginia announced that it sent a Dear Colleagues Letter to remind healthcare… Read more »
March 2, 2023 This Spring, the Florida Supreme Court will again review the intersection between the Patient Safety and Quality Improvement Act of 2005 (“PSQIA”) and Florida’s Amendment 7, the… Read more »
February 3, 2023 On January 30, 2023, President Biden announced his administration’s intent to end the COVID-19 Public Health Emergency (“PHE”) effective May 11, 2023. This change will impact providers… Read more »
January 10, 2023 On January 5, 2023, the Federal Trade Commission (“FTC”) proposed a sweeping rule that, if enacted as initially drafted, will prohibit employers from entering into or enforcing… Read more »
